The shareholders of the Swiss conglomerate SULZER have approved the complete sale of the medical technology subsidiary (cardiac implants) SULZER MEDICA. The industrial holding controls 74% of this subsidiary's capital. Furthermore, the Swiss investment company INCENTIVE CAPITAL could renounce its hostile take-over on SULZER, in which it holds close to 15 %, following the rejection by the board of the investment company's proposal to renew the industrial conglomerate's managerial team.